---
figid: PMC11011055__cancers-16-01334-g007
pmcid: PMC11011055
image_filename: cancers-16-01334-g007.jpg
figure_link: /pmc/articles/PMC11011055/figure/cancers-16-01334-f007/
number: Figure 7
figure_title: ''
caption: The use of small-molecule metabolic inhibitors, such as the fluorinated sialic
  acid analogue 3Fax-Neu5Ac, to obstruct the synthesis of sialylation pathway. As
  a result, the cell surface-expressed glycans are not capped with sialic acid, and
  their interaction with Siglecs is blocked.
article_title: Targeting Siglecâ€“Sialylated MUC1 Immune Axis in Cancer.
citation: Ramya Ayyalasomayajula, et al. Cancers (Basel). 2024 Apr;16(7):1334.
year: '2024'

doi: 10.3390/cancers16071334
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- MUC1
- Siglecs
- sialoglycans
- glycocode
- immune evasion

---
